| Synonyms: | |
| Status: | Approved (2019) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC18 |
| UNII: | 90ZX3Q3FR7 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-23 inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Arthritis, Psoriatic | 3 | D015535 | ClinicalTrials |
| Colitis, Ulcerative | 3 | D003093 | ClinicalTrials |
| Crohn Disease | 3 | D003424 | ClinicalTrials |
| Spondylitis, Ankylosing | 2 | D013167 | ClinicalTrials |
| Hidradenitis Suppurativa | 2 | D017497 | ClinicalTrials |
| Dermatitis | 2 | D003872 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3990029 |
| FDA SRS | 90ZX3Q3FR7 |
CONTENTS